Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03710031 · ClinicalTrials.gov registry record
Developing Self-Management Interventions After HCT
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 49
- Enrollment target
NCT03710031: Completed study, sponsored by University of Florida.
NCT03710031 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03710031 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
This is a prospective, longitudinal, observational trial to evaluate quality of life in hematopoietic stem cell transplant survivors.
Primary Outcome
Cytokines will be analyzed using a multiplex assay by Millipore Company. Compared to the traditional enzyme-linked immunosorbant assays (ELISA), the multiplex is comparable and more sensitive to lower concentration levels of cytokines than the ELISA. One laser identifies a specific bead and another laser identifies the reported antibody associated with the bead-bound cytokine. One hundred beads for each of the 17 cytokines in every sample are assayed and a mean cytokine binding for the sample is
Interventions
- OTHER PNS Tracking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2021-07-31 |
What the finished NCT03710031 record still lists
NCT03710031 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PNS Tracking is the first listed.
NCT03710031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03710031 about?
NCT03710031 is a clinical study titled "Developing Self-Management Interventions After HCT". This is a prospective, longitudinal, observational trial to evaluate quality of life in hematopoietic stem cell transplant survivors.
What is the current status of trial NCT03710031?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2019-02-04. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03710031?
The interventions under investigation include: PNS Tracking (OTHER).
Who is sponsoring clinical trial NCT03710031?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI